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ABSTRACT 
Floating drug delivery system is one of the novel drug delivery system. Floating drug delivery system have a bulk density less than gastric fluids 
and so remain buoyant in the stomach without affecting gastric emptying rate for a prolonged period of time. Various approaches have been 
used to retain the dosage form in stomach as a way of increasing the gastric residence time, including floatation systems, high-density systems, 
mucoadhesive systems, magnetic systems, unfoldable, extensible, or swellable systems and superporous hydrogel systems. The objective of this 
study was to prepare and evaluate floating microspheres of losartan potassium for the prolongation of gastric residence time.  The microspheres 
were prepared by solvent diffusion–evaporation method using ethyl cellulose, hydroxypropylmethylcellulose and sodium alginate as natural 
polymers. Ethanol/dichloromethane blend was used as solvent in a ratio of 1:2. The floating microspheres were evaluated for flow properties, 
particle size, zeta potential, drug entrapment, as well as In-vitro release studies and stability studies. The shape and surface morphology of the 
microspheres were characterized by optical and scanning electron microscopy. The floating microspheres showed particle size, buoyancy, drug 
entrapment efficiency and yield in the ranges of 331.6 nm, 69±3 to 81±2%, and 60.25±0.25 to 75.65±0.74% and 69.98±0.56 to81.47±0.52%, 
respectively. Maximum drug release after 12 hr was 99.45 % for formulations F4. Scanning electron micrographs indicate pores both on the 
surface and interior of the microspheres.  Accelerated stability study was also performed for three months indicated that optimized formulation 
was stable. The developed losartan microsphere system is a promising floating drug delivery system for oral sustained administration of 
losartan.  
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Several approaches have been developed to prolong the 
residence time of dosage forms in the stomach1. Various 
approaches have been used to retain the dosage form in the 
stomach as a way of increasing the gastric residence time 
(GRT), including floatation systems, high-density systems, 
mucoadhesive systems, magnetic systems, unfoldable, 
extendible, or swellable systems and superporous hydrogel 
systems2. Floating drug delivery systems (FDDS) or 
hydrodynamically balanced systems (HBS) are among the 
several approaches that have been developed to increase the 
GRT of dosage forms. Both single and multiple unit systems 
have been developed. The single- unit floating systems are 
more popular but have a disadvantage owing to their all-or-
nothing emptying process, leading to high variability of the 
gastrointestinal transit time3,4. In contrast, multiple-unit 
particulate dosage forms (e.g., microspheres) have the 
advantages that they pass uniformly through the 
gastrointestinal tract (GIT) to avoid the vagaries of gastric 
emptying and provide an adjustable release, thereby 
reducing the inter subject variability in absorption and risk 
of local irritation. Recently, hollow microspheres with a 
lower density than that of the GI fluids were adopted5. The 
floating microspheres were prepared by the emulsion 
solvent diffusion– evaporation technique using different 
polymer solution systems6, 7. Microspheres can be defined as 
solid, approximately spherical particles ranging in size from 
1 to 1000 μm range in diameter having a core of drug and 
entirely outer layers of polymers as coating material. They 
are made up of polymeric, waxy or other protective materials 
i.e. biodegradable synthetic polymer and modified natural 
products such as starches, gums, proteins, fats and waxes. 
Losartan potassium is an effective antihypertensive drug but 
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it undergoes hepatic first pass metabolism. Its half-life (t1/2) 
is 1.5-2 hrs and it should be administered 3-4 times to 
maintain plasma drug concentration8, 9. So, it requires 
control release of a drug. Hence an alternative drug delivery 
system is needed for increasing therapeutic efficacy, 
reducing the dosing frequency of drug and improving its 
half-life and bioavailability10.  Therefore, it is necessary to 
develop a newer formulation which releases the drug in a 
sustained release manner. Thus losartan potassium would 
become promising candidate for floating microspheres in the 
management of hypertension. Thus, the present study 
reports a novel attempt to prepare microspheres of 
antihypertensive drug losartan potassium by using natural 
polymers by solvent diffusion-evaporation method. 
MATERIALS AND METHODS 
Materials 
Losartan potassium were obtained as pure sample from Sun 
Pharmaceutical Industries Ltd. Dewas, as gift samples along 
with their analytical reports. Dichloromethane, ethanol and 
isopropyl alcohol were purchased from E. Merck (India) Ltd., 
Mumbai. Ethyl cellulose, hydroxyl propyl methyl cellulose 
and sodium alginate was purchased from Loba Chem. Pvt. 
Ltd, Mumbai All the other chemicals used were of analytical 
grade. 
Procedure for the determination of λ max 
Accurately weighed 10 mg of losartan potassium separately 
and dissolved in 10 ml of 0.1 N HCl in 10 ml of volumetric 
flask and prepared suitable dilution to make it to a 
concentration of 10 μg/ml make adequate of sample with 
concentration range of 5-25 μg/ml losartan potassium 
calculate the spectrum of this solution was run in 200-400 
nm range in U.V spectrophotometer. (Labindia UV 3000+) 
Preparation of floating microspheres  
Floating microspheres loaded with losartan potassium were 
prepared using solvent diffusion-evaporation method using 
HPMC,  EC and sodium alginate in different ratio like 1:0.5, 
1:0.75, 1:1 w/w. Drug and polymer in different proportion 
were dissolved in 1:2 mixture of solvent system of ethanol 
and dichloromethane. This clear solution was poured slowly 
in a thin stream into the aqueous solution of 1% polyvinyl 
alcohol. The emulsion was continuously stirred for 3 h at a 
speed of 500 rpm at 27±2°C. The floating microspheres were 
collected by decantation, while the non-floating 
microspheres were discarded. The microspheres were dried 
overnight at 40±2°C and stored in desicator11. The 
compositions of the formulations were shown in Table 1. 
Table 1 Formulations of the floating microspheres of 












F1 20 100 50 - 
F2 20 100 75 - 
F3 20 100 100 - 
F4 20 100 - 50 
F5 20 100 - 75 
F6 20 100 - 100 
F7 20 100 25 25 
F8 20 100 37.5 37.5 




Evaluation of microspheres           
Percentage yield 
The prepared microspheres with a size range of 1μm to 
1000μm were collected and weighed from different 
formulations. The measured weight was divided by the total 
amount of all non-volatile components which were used for 
the preparation of the microspheres. 
          
                                            
                                 
      
Drug entrapment 
The various formulations of the floating microspheres were 
subjected for drug content. 10 mg of floating microspheres 
from all batches were accurately weighed and crushed. The 
powder of microspheres were dissolved in 10 ml 0.1 N HCl 
and centrifuge at 1000 rpm. This supernatant solution is 
than filtered through whatmann filter paper No. 44. After 
filtration, from this solution 0.1 ml was taken out and diluted 
up to 10 ml with 0.1 N HCl. The percentage drug entrapment 
was calculated using calibration curve method. 
Floating behavior 
Ten milligrams of the floating microspheres were placed in 
0.1 N HCl (100 ml). The mixture was stirred at 100 rpm in a 
magnetic stirrer. After 10 h, the layer of buoyant 
microsphere was pipetted and separated by filtration. 
Particles in the sinking particulate layer were separated by 
filtration. Particles of both types were dried in desiccators 
until a constant weight was obtained. Both the fractions of 
microspheres were weighed and buoyancy was determined 
by the weight ratio of floating particles to the sum of floating 
and sinking particles. 
                  
                             
             
      
Measurement of mean particle size 
The mean size of the microspheres was determined by Photo 
Correlation Spectroscopy (PCS) on a submicron particle size 
analyzer (Horiba Instruments) at a scattering angle of 90°. A 
sample (0.5mg) of the microspheres suspended in 5 ml of 
distilled water was used for the measurement.   
Determination of zeta potential 
The zeta potential of the drug-loaded microspheres was 
measured on a zeta sizer (Horiba Instruments) by 
determining the electrophoretic mobility in a micro 
electrophoresis flow cell. All the samples were measured in 
water at 25°C in triplicate.   
Shape and surface characterization of microspheres by 
scanning electron microscopy (SEM) 
From the formulated batches of microspheres, formulations 
(F2) which showed an appropriate balance between the 
percentage releases were examined for surface morphology 
and shape using scanning electron microscope Jeol Japan 
6000. Sample was fixed on carbon tape and fine gold 
sputtering was applied in a high vacuum evaporator. The 
acceleration voltage was set at 10KV during scanning. 
Microphotographs were taken on different magnification and 
higher magnification (200X) was used for surface 
morphology.   
In-vitro release studies 
The drug release rate from Floating microspheres was 
carried out using the USP type II (Electro Lab.) dissolution 
paddle assembly. A weighed amount of Floating 
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microspheres equivalent to 100 mg drug were dispersed in 
900 ml of 0.1 N HCI (pH=1.2) maintained at 37±0.5°C and 
stirred at 55rpm. One ml sample was withdrawn at 
predetermined intervals and filtered and equal volume of 
dissolution medium was replaced in the vessel after each 
withdrawal to maintain sink condition. The collected 
samples analyzed spectrophotometrically at 277 nm to 
determine the concentration of drug present in the 
dissolution medium12.   
Drug release kinetic data analysis 
A number of kinetic models have been planned to explain the 
release characteristics of a drug from matrix. The next three 
equations are usually used, because of their simplicity and 
applicability. Equation 1, the zero-order model equation 
(Plotted as cumulative percentage of drug released vs time); 
Equation 2, Higuchi’s square-root equation (Plotted as 
cumulative percentage of drug released vs square root of 
time); and Equation 3, the Korsemeyer-Peppas equation 
(Plotted as Log cumulative percentage of drug released vs 
Log time). To study the release kinetics of stavudine from the 
mucoadhesive microspheres the release data was fitted to 
these three equations 13-15. 
Zero order equation 
When a graph of the cumulative percentage of the drug 
released from the matrix against time is plotted, zero order 
release is linear in such a plot, indicating that the release rate 
is independent of concentration. 
Qt = k0.t ……………………… (1) 
Where Qt is the percentage of drug released at time t and k0 is 
the releaserate constant; 
First order equation 
In (100-Qt) = In 100- kI.t ………………….. (2) 
Where kI is the release rate constant; 
Higuchi’s equation 
Qt = kH.t1/2    ……………………….. (3) 
Where KH is the Higuchi release rate constant 
Korsemeyer-Peppas 
The curves plotted may have different slopes, and hence it 
becomes difficult to exactly pin-point which curve follows 
perfect zero order release kinetics. Therefore, to confirm the 
kinetics of drug release, data were also analyzed using 
Korsemeyer’s equation. 
                                                 Qt/Q∞ = kKP.tn 
Where Qt/ Q∞ is the fraction of drug released at time t, kKPa 
constant compromising the structural and geometric 
characteristics of the device and n is the release exponent. 
The slope of the linear curve gives the ‘n’ value. Peppas 
stated that the above equation could adequately describe the 
release of solutes from slabs, spheres, cylinders and discs, 
regardless of the release mechanism. The value of ‘n’ gives an 
indication of the release mechanism. When n = 1, the release 
rate is independent of time (typical zero order release / case 
II transport); n = 0.5 for Fickian release (diffusion/ case I 
transport); and when 0.5 < n < 1, anomalous (non-Fickian or 
coupled diffusion/ relaxation) are implicated. Lastly, when n 
> 1.0 super case II transport is apparent.  ‘n’ is the slope 
value of log Mt/M∞   versus log time curve16. 
 
 
Stability studies for optimized formulation 
Accelerated testing, are the studies designed to amplify the 
rate of chemical degradation or physical change of a drug 
substance or drug product by exaggerated storage conditions 
as part of the formal stability studies. The optimized 
formulation F4 was taken and accelerated stability study was 
performed by taking suitable quantity of microspheres. The 
microspheres were placed in air-tight glass container at 
40±2°C/75±5% RH. At suitable sampling interval the 
samples were withdrawn and evaluated for various 
parameters. 
RESULTS AND DISCUSSION 
Solubility of losartan was freely soluble in water, 0.1N HCl, 
methanol and ethanol, slightly soluble in 0.1N NaOH and 
chloroform. The melting point and partition coefficient of 
losartan was found to be 183.5 -184.5°C and 1.21±0.001 
respectively.  The λ max of losartan was found to be 277 nm by 
using U.V. spectrophotometer (Labindia-3000+) in linearity 
range 5-25 µg/ml Fig.1& 2. IR spectrum of any compound 
given information about the functional group present in 
particular compound.  IR spectrum of losartan and with all 
excipients was taken using KBr pellet method. Various peaks 
in IR spectrum were interpreted for presence of different 
group in the structure of drug. The spectra of FTIR (Fig.3 to 
4) indicate that the sample used was losartan and no 
interference with drug and excipients. The floating 
microspheres of losartan were prepared by solvent 
diffusion-evaporation method. Percentage yield of different 
formulation was determined by weighing the microspheres 
after drying.  The percentage yield of different formulation 
was in range of 69.98±0.56 to 81.47±0.52 % Table 2.  
 
Fig. 1 Determination of λmax of losartan potassium 
 
 
Fig.2 Calibration curve of losartan potassium at 277 nm 
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Fig. 3 FT-IR Spectrum of Pure Drug (losartan potassium) 
 
Fig. 4 FT-IR spectrum of pure drug (losartan potassium + 
all excipients) 
 
Table 2 Percentage yield for different formulation 
Formulation Percentage Yield* 
F1 70.23±0.45 
F2 75.65±0.32 







*Average of three determination (N=3) 
The drug entrapment efficacies of different formulations 
were in range of 60.25±0.25 to 75.65±0.74 w/w Table 3. F4 
microspheres entrapped maximum amount of the drug. To 
assess the floating properties, the microspheres were placed 
in 0.1N hydrochloric acid. The microspheres floated for 
prolonged time over the surface of the dissolution medium 
without any apparent gelation. Buoyancy percentage of the 
microspheres was in the range of 69±3 to 81±2. The nature 
of the polymer influenced the floating behaviour of the 
microspheres Table 4. The maximum percentage yield, drug 
entrapment, percentage buoyancy and floating lag time was 
found to be formulation F4 in floating microsphere. The 
optimized formulation of both batches subjected to further 
studies.The mean size of the microspheres was determined 
by photo correlation spectroscopy (PCS) on a submicron 
particle size analyzer (Horiba Instruments) at a scattering 
angle of 90°.The results of measurement of mean particle 
size of optimized formulation F4 of floating microsphere was 
found to be 331.6 nm nm Fig. 5. Results of zeta potential of 
optimized formulation F4 of floating microsphere was found 
-25.9 mV Fig. 6. 
Table 3 Drug entrapment for different formulations 
Formulation 








F7 60.25±0.25  
F8 69.98±0.32 
F9 70.23±0.45 
*Average of three determination (N=3) 







F1 65±5 69±3 
F2 62±8 72±2 
F3 69±6 69±3 
F4 42±7  81±2 
F5 55±8 75±4 
F6 69±9 70±5 
F7 85±6 69±5 
F8 96±5 75±2 
F9 95±4 70±1 
 
 
Fig. 5 Particle size data of optimized microsphere formulation F4  
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Fig. 6 Zeta potential data of floating microsphere F4 
 
The drug release from floating microspheres was found to be 
99.45% at the end of 12 h for F4 Table 5. The In vitro drug 
release data of the optimized formulation was subjected to 
goodness of fit test by linear regression analysis according to 
zero order and first order kinetic equation, in order to 
determine the mechanism of drug release. When the 
regression coefficient values were compared, it was 
observed that an ‘r’ value of microsphere was maximum 
zero order i.e 0.978 hence indicating drug releases from 
formulations was found to follow zero order for floating 
microsphere Table 6 & 7 and Fig.7 & 8. 
 
Table 5 Release study data of formulation F1-F9 
Time % of Drug Release 
(hr) F1 F2 F3 F4 F5 F6 F7 F8 F9 
0.5 45.56 33.56 33.56 24.46 28.89 27.98 30.25 21.65 18.89 
1 69.98 50.23 50.23 32.25 39.98 35.65 48.98 30.45 22.23 
2 77.89 65.58 65.58 40.56 48.78 45.58 55.69 39.23 35.65 
4 98.98 73.36 73.36 52.32 58.98 55.69 60.25 49.32 40.23 
6 - 98.89 98.89 70.23 79.98 75.65 85.65 60.85 55.56 
8 - - - 85.56 98.98 92.56 99.56 78.85 70.23 
10 - - - 95.56 - 98.12 - 89.98 79.89 
12 - - - 99.45 - - - 94.36 85.56 
 




















0.5 0.707 -0.301 24.46 1.388 75.54 1.878 
1 1 0 32.25 1.509 67.75 1.831 
2 1.414 0.301 40.56 1.608 59.44 1.774 
4 2 0.602 52.32 1.719 47.68 1.678 
6 2.449 0.778 70.23 1.847 29.77 1.474 
8 2.828 0.903 85.56 1.932 14.44 1.160 
10 3.162 1 95.56 1.980 4.44 0.647 
12 3.464 1.079 99.45 1.998 0.55 -0.260 
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Fig. 7 Zero order release kinetics graph of optimized 
formulations 
 
Fig. 8 First order release kinetics graph of optimized 
formulations 
Table 7 Comparative study of regression coefficient for 
selection of optimized Formulation F-4 
Release Kinetics Zero order First order 
r2 0.978 0.867 
 
According to ICH guidelines, 3 months accelerated stability 
study at 40±2°c and 75±5% RH optimized formulations (F4) 
was carried out. It showed negligible change over time for 
parameters like appearance, drug content, dissolution and 
assay etc., No significant difference observed  in the drug 
content between initial and formulations stored at 40±2°c & 
75±5% RH for 3 months. 
CONCLUSION 
In vitro data obtained for floating microspheres of losartan 
showed excellent floatability, good buoyancy and prolonged 
drug release. Microspheres of different size and drug content 
could be obtained by varying the formulation variables. Thus, 
the prepared floating microspheres may prove to be 
potential candidates for multiple-unit delivery devices 
adaptable to any intragastric condition. Hydrophilic matrix 
of HPMC and EC alone could not control the release of drug 
effectively for 12 hours and the release pattern was 
satisfactory. The use of EC and sodium alginate along with 
HPMC proved to show better retarding ability which was 
clearly seen from the results. 
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